| 序号 |
批准日期 |
商品名 |
活性成分 |
公司全称 |
注册审批号 |
规格 |
剂型/给药途径 |
参比药物 |
参比标准 |
市场状态 |
| 1 |
2026-03-31 |
MESALAMINE |
MESALAMINE |
KLM LABS PVT |
|
4GM/60ML |
ENEMA;RECTAL |
No |
No |
RX |
| 2 |
2026-03-31 |
METHYLENE BLUE |
METHYLENE BLUE |
ZYDUS LIFESCIENCES |
|
100MG/10ML (10MG/ML) |
SOLUTION;INTRAVENOUS |
No |
Yes |
RX |
| 3 |
2026-03-31 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
SCIEGEN PHARMS |
|
12.5MG;20MG |
TABLET;ORAL |
No |
No |
RX |
| 4 |
2026-03-31 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
SCIEGEN PHARMS |
|
12.5MG;40MG |
TABLET;ORAL |
No |
No |
RX |
| 5 |
2026-03-31 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
SCIEGEN PHARMS |
|
25MG;40MG |
TABLET;ORAL |
No |
No |
RX |
| 6 |
2026-03-30 |
LIRAGLUTIDE |
LIRAGLUTIDE |
FRESENIUS KABI USA |
|
18MG/3ML (6MG/ML) |
SOLUTION;SUBCUTANEOUS |
No |
No |
RX |
| 7 |
2026-03-30 |
BENZONATATE |
BENZONATATE |
MARKSANS PHARMA |
|
100MG |
CAPSULE;ORAL |
No |
No |
RX |
| 8 |
2026-03-30 |
BENZONATATE |
BENZONATATE |
MARKSANS PHARMA |
|
200MG |
CAPSULE;ORAL |
No |
No |
RX |
| 9 |
2026-03-30 |
EPINEPHRINE |
EPINEPHRINE |
BAXTER HLTHCARE CORP |
|
1MG/ML (1MG/ML) |
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
Yes |
Yes |
RX |
| 10 |
2026-03-30 |
EPINEPHRINE |
EPINEPHRINE |
BAXTER HLTHCARE CORP |
|
30MG/30ML (1MG/ML) |
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
Yes |
Yes |
RX |